e-Therapeutics plc (LON:ETX)’s share price passed above its fifty day moving average during trading on Wednesday . The stock has a fifty day moving average of $2.98 and traded as high as $4.09. e-Therapeutics shares last traded at $3.90, with a volume of 529,262 shares changing hands.
The firm has a market cap of $10.19 million and a price-to-earnings ratio of -2.53. The business’s fifty day moving average is GBX 3.01 and its two-hundred day moving average is GBX 3.03.
e-Therapeutics Company Profile (LON:ETX)
e-Therapeutics plc engages in the discovery of drugs through its proprietary network-driven drug discovery platform in the United Kingdom. It is developing two NDD-derived immuno-oncology programs, including tryptophan catabolism and immune checkpoint modulation. The company, through its subsidiary, Searchbolt Limited, develops search engine technology.
Featured Story: What is a Leveraged Buyout (LBO)?
Receive News & Ratings for e-Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for e-Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.